Literature DB >> 1698126

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

M L Drumm1, H A Pope, W H Cliff, J M Rommens, S A Marvin, L C Tsui, F S Collins, R A Frizzell, J M Wilson.   

Abstract

We have used retrovirus-mediated gene transfer to demonstrate complementation of the cystic fibrosis (CF) defect in vitro. Amphotropic retroviruses were used to transduce a functional cystic fibrosis transmembrane conductance regulator (CFTR) cDNA into CFPAC-1, a pancreatic adenocarcinoma cell line derived from a patient with CF that stably expresses the chloride transport abnormalities characteristic of CF. CFPAC-1 cells were exposed to control virus (PLJ) and CFTR-expressing virus (PLJ-CFTR); viral-transduced clones were isolated and subjected to molecular and physiologic analysis. RNA analysis detected a viral-derived CFTR transcript in all of the PLJ-CFTR clones that contained unrearranged proviral sequences. Agents that increase intracellular cAMP stimulated 125I efflux in PLJ-CFTR clones but not PLJ clones. Whole-cell patch-clamp performed on three responding clones showed that the anion efflux responses were due to cAMP stimulation of Cl conductance. Our findings indicate that expression of the normal CFTR gene confers cAMP-dependent Cl channel regulation on CF epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698126     DOI: 10.1016/0092-8674(90)90398-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

1.  Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

Authors:  C L Halbert; T A Standaert; M L Aitken; I E Alexander; D W Russell; A D Miller
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor.

Authors:  A G Ziady; J C Perales; T Ferkol; T Gerken; H Beegen; D H Perlmutter; P B Davis
Journal:  Am J Physiol       Date:  1997-08

3.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

4.  In vivo retroviral gene transfer into human bronchial epithelia of xenografts.

Authors:  J F Engelhardt; J R Yankaskas; J M Wilson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.

Authors:  R Ratcliff; M J Evans; J Doran; B J Wainwright; R Williamson; W H Colledge
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

Review 6.  Outwardly rectifying chloride channels and CF: a divorce and remarriage.

Authors:  W B Guggino
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

7.  Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression.

Authors:  J C Olsen; L G Johnson; M L Wong-Sun; K L Moore; R Swanstrom; R C Boucher
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

8.  Antisense oligodeoxynucleotide to the cystic fibrosis transmembrane conductance regulator inhibits cyclic AMP-activated but not calcium-activated cell volume reduction in a human pancreatic duct cell line.

Authors:  H Kopelman; C Gauthier; M Bornstein
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR.

Authors:  P J Thomas; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

10.  Ketoconazole activates Cl- conductance and blocks Cl- and fluid absorption by cultured cystic fibrosis (CFPAC-1) cells.

Authors:  U Kersting; D Kersting; K R Spring
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.